Dr. Reddy's Laboratories (RDY) revenue

Revenue · fiscal 2026
₹335.93B

Dr. Reddy's Laboratories (RDY) reported revenue of ₹335.93B in fiscal 2026 (the year ended March 31, 2026). That is 3.2% higher than the ₹325.54B of fiscal 2025. Figures as of 18 Nov 2026, 11:57 UTC, from Yahoo Finance.

Key facts

Revenue, fiscal 2026
₹335.93B
Change on fiscal 2025
+3.2%
Highest on record
₹335.93Bfiscal 2026
Lowest on record
₹245.88Bfiscal 2023
Fiscal years on record
42023–2026

Figures as of . Statements from Yahoo Finance. Amounts are in INR. Figures, not advice.

Dr. Reddy's Laboratories revenue, in more detail

Across the 4 fiscal years on record (2023–2026), the highest was ₹335.93B in fiscal 2026 and the lowest ₹245.88B in fiscal 2023.

History · 4 fiscal years

Revenue by fiscal year

Dr. Reddy's Laboratories revenue, year by year

Dr. Reddy's Laboratories (RDY) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2026₹335.93B 3.2% up
2025₹325.54B 16.6% up
2024₹279.16B 13.5% up
2023₹245.88B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Dr. Reddy's Laboratories and comparable companies
CompanyRevenueFiscal year
Smith & Nephew SNN$6.16B2025
Penumbra PEN$1.40B2025
Dr. Reddy's Laboratories RDY₹335.93B2026
Align Technology ALGN$4.03B2025
Cooper Companies COO$4.09B2025
Fresenius Medical Care FMS€19.63B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RDY

Dr. Reddy's Laboratories, figure by figure

Dr. Reddy's Laboratories (RDY) overview: price, valuation and scorecardAll health care companies by market value

Dr. Reddy's Laboratories revenue: questions and answers

What is Dr. Reddy's Laboratories's revenue?

Dr. Reddy's Laboratories (RDY) reported revenue of ₹335.93B in fiscal 2026 (the year ended March 31, 2026). That is 3.2% higher than the ₹325.54B of fiscal 2025.

What are the highest and lowest revenue figures on record for Dr. Reddy's Laboratories?

Across the 4 fiscal years on record (2023–2026), the highest was ₹335.93B in fiscal 2026 and the lowest ₹245.88B in fiscal 2023.

How is Dr. Reddy's Laboratories's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Dr. Reddy's Laboratories it is on record here for 4 fiscal years, 2023 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Dr. Reddy's Laboratories (RDY) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/RDY/revenue

Underlying data: Yahoo Finance.